You are here

  • Home
  • Archive
  • Volume 80, Issue 8
  • Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial

Article metrics

Article menu
Download PDFPDF
Rheumatoid arthritis
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial

 

Online download statistics by month:

Online download statistics by month: April 2021 to March 2024

AbstractFullPdf
Apr 20212671207176
May 20217709956
Jun 2021332717
Jul 202120619098
Aug 202117415367
Sep 2021787340
Oct 20214384127
Nov 20212632811
Dec 2021314367
Jan 20222391712
Feb 2022346286
Mar 2022312447
Apr 20222374314
May 20222572612
Jun 20222954012
Jul 20222402512
Aug 2022253226
Sep 20221871110
Oct 202219185
Nov 2022135101
Dec 202211485
Jan 2023108127
Feb 20231551310
Mar 20237782
Apr 202310372
May 202394102
Jun 2023120123
Jul 202370164
Aug 202371108
Sep 20234555
Oct 20235284
Nov 2023110133
Dec 202399172
Jan 202412575
Feb 20249341
Mar 20248842
Total91631282661